On 26 April 2023, the European Commission published the proposal for the revision of the EU Pharmaceutical legislation, which also includes provisions on medicines for rare diseases and children. SIOPE and CCI Europe have identified six key priority areas which require focused consideration during the negotiation of the revised EU Pharmaceutical legislation. We have detailed in our joint position paper areas which should be upheld, as well as areas with specific suggestions for amendments which can further strengthen the reform and ultimately, improve the outcomes of patients with unmet medical needs such as young cancer patients and restore them to their full health.
READ THE FULL POSITION PAPER HERE
Now we are asking our members to add their voices and experiences to shape the legislative debate process. Please consider completing the EU Commission’s consultation on the revised EU Pharmaceutical Legislation. Your individual responses and spreading the information to your network is key as legislators will take into account the number of replies. All feedback received will be summarised by the European Commission and presented to the European Parliament and Council with the aim of feeding into the EU Pharmaceutical legislative debate.
To help you, we have created a toolkit providing helpful instructions and insights into this important policy development.
It is crucial to take a decisive step forward for the benefit of children with cancer with a swift negotiation and adoption of the European Commission’s proposal. We must also move towards its prompt implementation to accelerate innovation for children with cancer. We hope you will add your voice so that together, we can strive for a brighter future for children and young people with cancer.
Find the full information on the revision of the Pharma Legislation and the EU Commissions Consultation on our website here.
Do not hesitate to inform your colleagues to join as well and share within their networks.
For queries or further information, please send an email to: sonja.ladenstein@siope.eu or ciara.sheehan@siope.eu